Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Broad Institute · Howard Hughes Medical Institute · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
538
total citations
- FWCI
- 24.78
- Percentile
- 100%
- References
- 28
Citations per year
Authors
20- XGXue GaoCorresponding
Broad Institute, Howard Hughes Medical Institute, Harvard University
- YTYong Tao
Massachusetts Eye and Ear Infirmary, Union Hospital, Harvard University, Huazhong University of Science and Technology
- VLVerónica Lamas
Massachusetts Eye and Ear Infirmary, Harvard University
- MHMingqian Huang
Massachusetts Eye and Ear Infirmary, Harvard University
- WYWei-Hsi Yeh
Broad Institute, Howard Hughes Medical Institute, Harvard University, Harvard University Press
Topics & keywords
Topics
Keywords
- Hearing loss
- Allele
- Genome editing
- Biology
- Genetics
- In vivo
- Cochlea
- Cas9
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.